Regulatory guidance and the changes that will occur surrounding social media in pharmaceuticals

Jan. 5, 2012 - PRLog -- SMi 3rd annual conference on.....
Social Media in the Pharmaceutical Industry
Insight, strategy and imagination in successfully harnessing digital and social media
Tuesday 24th & Wednesday 25th January 2012, Copthorne Tara Hotel, London

SMi’s 3rd annual Social Media in the Pharmaceutical Industry conference, the premier event of its kind in Europe and the only event to focus exclusively on how social media can be used within the pharmaceutical industry and healthcare.

At this event you will hear about the regulatory ‘guidance’ and the changes that will occur surrounding social media in pharmaceuticals, case studies from big pharma companies, Alex Butler’s input on the impact of social media in pharmaceuticals and what action needs to be taken to foster patient-doctor interaction.

Our key presenters include:

Andrew Widger, Director, Media Relations, EMEA, Pfizer
John Pugh, Director of Digital and Online Communications, Boehringer Ingelheim
Juan Ramon Amaros, e-Business Manager, Boehringer Ingelheim Espana
Glenn Byrd, Senior Director, Regulatory Affairs, MedImmune
Alex Butler, Founder & Managing Director, The Social Moon
John Vieira, Senior Director, Marketing Operations & Strategic Services, Daiichi Sankyo
Sara James, Global Enrolment Consultant for Europe, Lilly
Francisco Abad-Marin, Marketing Manager, Respiratory Centre of Excellence, GSK
Tova Turkel, Head of Social Media, British Lung Foundation
John Robinson, User Generated Contact Lead, NHS Choices
Rob Benson, Ecommunications Specialist, NHS Birmingham
Alex Talbott, Communications Officer, NHS Institute for Innovation and Improvement
Carl Plant, Community Manager (NHS Local), Maverick Television
Nick Broughton, Managing Director, Pharmaceuticalethics.com
Gary Monk, Managing Director UK, Across Group
Kate Smith, Solicitor, Shoosmiths

For more information visit http://www.smi-online.co.uk/pharma-socialmedia5.asp